Form 4: Edgewise Therapeutics Director Arlene Morris Reports Stock Option Grant
SEC Form 4
Director Arlene Morris of Edgewise Therapeutics, Inc. reports the acquisition of stock options.
Summary
- Arlene Morris, a director of Edgewise Therapeutics, Inc., filed a Form 4 disclosing a transaction.
- On June 10, 2024, Morris acquired 20,594 stock options with an exercise price of $17.13.
- These options vest on the earlier of June 10, 2025, or the day before the 2025 annual meeting of stockholders and expire on June 10, 2034.
- Following the transaction, Morris directly owns 20,594 derivative securities.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't contain information that would significantly sway investor sentiment positively or negatively.
Industry Context
This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It provides transparency into the equity-based compensation of company directors.
Comparison to Industry Standards
- Stock option grants are a common form of compensation for directors in publicly traded companies, particularly in the biotechnology sector.
- The vesting schedule of the options, contingent on the annual meeting or a specific date, is a standard practice to align director interests with shareholder value.
- Comparable companies in the biotechnology industry, such as BioMarin Pharmaceutical or Vertex Pharmaceuticals, also utilize stock options as part of their director compensation packages.
Stakeholder Impact
- The stock option grant aligns the director's interests with those of the shareholders, incentivizing her to work towards increasing the company's value.
Key Dates
| Date | Description |
|---|---|
| 2024-05-06 | Date of Power of Attorney execution. |
| 2024-06-10 | Date of stock option grant. |
| 2024-06-10 | Stock options become exercisable on the earlier of this date or the business day prior to the 2025 annual meeting of stockholders. |
| 2024-06-12 | Date of Form 4 filing. |
| 2034-06-10 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.